131I-omburtamab Delivered by Convection-Enhanced Delivery in Patients With Diffuse Intrinsic Pontine Glioma

NCT05063357 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Corporate business decision. Not due to safety or efficacy concerns.

Conditions

DIPG

Interventions

DRUG: 131I-Omburtamab
DEVICE: Convention Enhanced Delivery

Sponsor

Y-mAbs Therapeutics

Collaborators

[object Object]
[object Object]